|
2017
|
Invention
|
Method for preparing eperisone sustained release microsphere, and composite preparation of eperis... |
|
2016
|
Invention
|
Pharmaceutical composition for treating renal diseases, containing dipyridamole as active ingredi... |
|
|
Invention
|
Method for manufacturing core-shell type sustained-release pellets containing dipyridamole as act... |
|
|
Invention
|
Composite preparation of dipyridamole sustained-release pellets and aspirin. The present inventio... |
|
2014
|
Invention
|
Pharmaceutical dosage form for treating chronic myeloid leukemia, containing liriodendron tulipif... |
|
|
Invention
|
Pharmaceutical composition for treating chronic myeloid leukemia, containing liriodendron tulipif... |
|
|
Invention
|
Method for separating therapeutic agent for chronic myelogenous leukemia from bark of liriodendro... |
|
|
Invention
|
Pharmaceutical composition containing liriodendron tulipifera l. extract for treating chronic mye... |
|
|
Invention
|
Eperisone pharmaceutical composition having improved preservability and ph stability. The present... |
|
|
Invention
|
Sustained-release medicinal composition containing eperisone as active ingredient. The present in... |
|
2013
|
Invention
|
Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases.
T... |
|
|
Invention
|
Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases. Th... |
|
|
Invention
|
Method for extracting treatment ingredients for gastrointestinal diseases from bark of liriodendr... |
|
|
Invention
|
Dosage form containing extract from bark of liriodendron tulipifera as active ingredient.
The pr... |
|
|
Invention
|
Pharmaceutical composition containing as active ingredient extract from bark of liriodendron tuli... |
|
|
Invention
|
Improved dosage form containing extract from bark of liriodendron tulipifera as active ingredient... |
